default search action
"PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers ..."
Patricio Oyarzún et al. (2013)
- Patricio Oyarzún, Jonathan J. Ellis, Mikael Bodén, Bostjan Kobe:
PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BMC Bioinform. 14: 52 (2013)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.